title: BuMPing iron with modified heparins.
abstract: In this issue of Blood, Poli et al demonstrate that heparin analogs engineered to minimize their anticoagulant properties can potently downregulate hepcidin production in vitro and in vivo, and may potentially be used to treat the anemia of inflammation.
authors.affiliation: MASSACHUSETTS GENERAL HOSPITAL.
authors.forename: Jodie L
authors.initials: JL
authors.lastname: Babitt
authors.forename: Herbert Y
authors.initials: HY
authors.lastname: Lin
mesh_terms: D000818:Animals; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects*; D006493:Heparin / Q000031:analogs & derivatives* / Q000494:pharmacology; D064451:Hepcidins / Q000235:genetics*; D006801:Humans
chemical_list: D064451:Hepcidins; C504902:RO-heparin; D006493:Heparin